Clinical problems posed by multiresistant nonfermenting gram-negative pathogens

Clinical Infectious Diseases

Volumn 27, Issue SUPPL.1, 1998, Pages

  Quinn, John P ^a,b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b M/C 787 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BURKHOLDERIA CEPACIA; CONFERENCE PAPER; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA;

ACINETOBACTER BAUMANNII; BURKHOLDERIA CEPACIA; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA;

EID: 0031904174     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514912     Document Type: Conference Paper

References (12)

1. Itokazu GS, Quinn JP, Bell-Dixon C, Kahan FM, Weinstein RA. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive-care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis 1996;23:779-84.
2. Burwen DR, Banerjee SN, Gaynes RP. Ceftazidime resistance among selected gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System. J Infect Dis 1994;170:1622-5.
3. Chow J, Fine M, Hooper D, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991;115:585-91.
4. Jacobsen KL, Cohen SH, Inciardi JF, et al. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I β-lactamase-producing organisms. Clin Infect Dis 1995;21:1107-13.
5. Manian FA, Meyer L, Jenne J, Owen A, Taff T. Loss of antimicrobial susceptibility in aerobic gram-negative bacilli repeatedly isolated from patients in intensive-care-units. Infect Control Hosp Epidemiol 1996;17:222-6.
6. Jarvis WR, Martone WJ. Predominant pathogens in hospital infections. J Antimicrob Chemother 1992;29(suppl A):19-24.
7. Hilf M, Yu VL, Sharp J, Zuravleff JJ, Korvick JA, Muder RR. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med 1989;87:540-6.
8. Laughlin TJ, Armstrong DG, Caporusso J, Lavery LA. Soft tissue and bone infections from puncture wounds in children. West J Med 1997;166:126-8.
9. Pedersen HB, Rosborg J. Necrotizing external otitis: aminoglycoside and beta-lactam antibiotic treatment combined with surgical treatment. Clin Otolaryngol 1997;22:271-4.
10. Flores G, Stavola JJ, Noel GJ. Bacteremia due to Pseudomonas aemginosa in children with AIDS. Clin Infect Dis 1993;16:706-8.
11. O'Donnell JG, Sorbello AF, Condoluci DV, Barnish MJ. Sinusitis due to Pseudomonas aeruginosa in patients with human immunodeficiency virus infection. Clin Infect Dis 1993;16:404-6.
12. Kielhofner M, Atmar RL, Hamill RJ, Musher DM. Life-threatening Pseudomonas aeruginosa infections in patients with human immunodeficiency virus infection. Clin Infect Dis 1992;14:403-11.